HematologyNews.net

Hematology Xagena

Search results for "Deferasirox"

Blood Products Advisory Committee ( BPAC ) of the FDA ( Food and Drug Administration ) has given a positive review of Exjade ( Deferasirox ). Exjade is once-daily oral iron chelator for the trea ...


Novartis has informed Healthcare Professional on the safety of Exjade ( Deferasirox ), which is indicated for the treatment of chronic iron overload due to frequent blood transfusions, or when Desfera ...


The Committee for Medicinal Products for Human Use ( CHMP ) finalised its assessment of an application to modify the use of Exjade from second- to first-line treatment in patients aged six years and o ...


Results from THALASSA, the first pivotal placebo-controlled study examining the benefit of iron chelation with Exjade ( Deferasirox ) in patients with non-transfusion-dependent thalassemia ( NTDT ), w ...